Gilead Sciences (GILD)

EBITDA

$1.33B

TTM · Period ending: · USD

GILD logo

GILD EBITDA

Latest reported$1.33B
GILD TTM EBITDA (-$4.00M → $1.33B)
High-resolution chart · PNG

GILD ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-86,205,000
-58,469,000
-37,670,000
-29,040,000
-34,209,000
-40,966,000
-52,968,000
-65,868,000
-55,468,000
-65,260,000
-63,200,000
-60,300,000
-61,600,000
-43,200,000
-42,800,000
-37,600,000
-17,000,000
-30,400,000
-31,500,000
-28,800,000
-43,000,000
-37,800,000
-32,000,000
-30,200,000
-29,500,000
-28,900,000
-29,200,000
-28,300,000
-26,400,000
-24,600,000
-22,000,000
-19,200,000
-16,300,000
-17,000,000
-12,400,000
-8,900,000
-6,300,000
-4,000,000
-4,400,000
-4,500,000
-4,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.